What are the efficacy and safety of psilocybin in patients with major depressive disorder?

Roche announced the agreement at its annual pharma day in London, UK. Image shows Roche’s head office in California, USA. Credit: Michael Vi via Shutterstock.

Staging locally advanced breast cancer patients with 18F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases — and thus reduced the number of patients who received